These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9789907)

  • 1. Attentional improvement following quetiapine fumarate treatment in schizophrenia.
    Sax KW; Strakowski SM; Keck PE
    Schizophr Res; 1998 Oct; 33(3):151-5. PubMed ID: 9789907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine.
    Khouzam HR
    Depress Anxiety; 2000; 11(2):80-2. PubMed ID: 10812533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.
    Zhong KX; Sweitzer DE; Hamer RM; Lieberman JA
    J Clin Psychiatry; 2006 Jul; 67(7):1093-103. PubMed ID: 16889453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.
    Meisenzahl EM; Scheuerecker J; Zipse M; Ufer S; Wiesmann M; Frodl T; Koutsouleris N; Zetzsche T; Schmitt G; Riedel M; Spellmann I; Dehning S; Linn J; Brückmann H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):522-31. PubMed ID: 17151834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.
    Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S
    J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
    Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine.
    Vesely C; Küfferle B; Brücke T; Kasper S
    Int Clin Psychopharmacol; 2000 Jan; 15(1):57-60. PubMed ID: 10836289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
    Riedel M; Müller N; Strassnig M; Spellmann I; Engel RR; Musil R; Dehning S; Douhet A; Schwarz MJ; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):432-7. PubMed ID: 16267634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine-associated depression in a patient with schizophrenia.
    Mergui J; Jaworowski S; Lerner V
    Clin Neuropharmacol; 2005; 28(3):133-5. PubMed ID: 15965312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine: efficacy and tolerability in schizophrenia.
    Kasper S; Tauscher J; Heiden A
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S405-13. PubMed ID: 11587888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E; Valsecchi P; Parrinello G;
    Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 'Seroquel' (quetiapine) on platelet serotonin-2 binding in schizophrenia.
    Faustman WO; Ringo DL; Lauriello J; Lim KO; Pfefferbaum A
    J Clin Psychopharmacol; 1996 Dec; 16(6):464-6. PubMed ID: 8959478
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.
    Voruganti LP; Awad AG; Parker G; Forrest C; Usmani Y; Fernando ML; Senthilal S
    Schizophr Res; 2007 Nov; 96(1-3):146-55. PubMed ID: 17728106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.
    Kelly DL; Conley RR
    J Clin Psychiatry; 2005 Jan; 66(1):80-4. PubMed ID: 15669892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis.
    Good KP; Kiss I; Buiteman C; Woodley H; Rui Q; Whitehorn D; Kopala L
    Br J Psychiatry Suppl; 2002 Sep; 43():s45-9. PubMed ID: 12271800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.